At its meeting on 9 February 2023, the Board of Directors found that 100% of the performance conditions were achieved during the three years taken into consideration by the ACAs plan of 18 April 2019, namely 2020, 2021 and 2022. Accordingly, the beneficiaries who fulfil the conditions under the plan of 18 April 2023 and, in particular, that relating to the condition of presence in the Company, will receive 100% of the shares that were granted to them.
For information purposes, 24,000 shares were granted to the corporate officer, under the Plan of 18 April 2019. After application of the performance conditions, 24,000 shares will be fully vested by Mr Jean-Paul Agon, the Chairman and Chief Executive Officer at the time they were granted.
| ACAs plan of 18 April 2019 | 2020 | 2021 | 2022 | Arithmetic average of performances for 2020, 2021 and 2022 |
|---|---|---|---|---|
| 50% growth in like-for-like sales compared to a panel of competitors* | 50% growth in like-for-likesales compared to a panel of competitors* 2020+4.0 points(-4.1%/-8.1%) |
50% growth in like-for-likesales compared to a panel of competitors* 2021+6.9 points(+16.1%/+9.2%) |
50% growth in like-for-likesales compared to a panel of competitors* 2022+7.3 points (+10.9% / +3.6%) |
50% growth in like-for-likesales compared to a panel of competitors* Arithmetic average of performances for 2020, 2021 and 2022+6.1 points |
| 50% growth in the Group’s operating profit | 50% growth in the Group’s operating profit 2020-6.10%(5,547.5/5,209.0) |
50% growth in the Group’s operating profit 202118.30%(5,209.0/6,160.3) |
50% growth in the Group’s operating profit 2022+21.0%(6,160.3 / 7,456.9) |
50% growth in the Group’s operating profit Arithmetic average of performances for 2020, 2021 and 2022+11.1% |
*The panel consists of the following companies: Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao and Coty.
| ACAs plan of 14 October 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|
| 50% growth in like-for-like sales compared to a panel of competitors* | 50% growth in like-for-like sales compared to a panel of competitors* 2021+ 6.9 points(+16.1%/+9.2%) |
50% growth in like-for-like sales compared to a panel of competitors* 2022+7.3 points (+10.9% / +3.6%) |
50% growth in like-for-like sales compared to a panel of competitors* 2023pending |
| 50% growth in the Group’s operating profit | 50% growth in the Group’s operating profit 202118.30%(5,209.0 / 6,160.3) |
50% growth in the Group’s operating profit 2022+21.0%(6,160.3 /7,456.9) |
50% growth in the Group’s operating profit 2023pending |
| ACAs plan of 07 October 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|
| 50% growth in like-for-like sales compared to a panel of competitors* | +7.3 points (+10.9% / +3.6%) |
pending | pending |
| 50% growth in the Group’s operating profit | +21.0% (6,160.3 /7,456.9) |
pending | pending |
| ACAs plan of 13 October 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
|
pending | pending | pending |
|
pending | pending | pending |
*The panel consists of the following companies: Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao and Coty.
